Composition
- Active ingredients
- TAPENTADOL 200MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TAPENTADOL 50MG · TabletANDA205015-001 · Tentative approval
- TAPENTADOL 75MG · TabletANDA205015-002 · Tentative approval
- TAPENTADOL 100MG · TabletANDA205015-003 · Tentative approval
- TAPENTADOL 200MG · Tablet, extended releaseANDA206418-004 · Tentative approval
- TAPENTADOL 100MG · Tablet, extended releaseANDA206418-002 · Tentative approval
- TAPENTADOL 250MG · Tablet, extended releaseANDA206418-005 · Tentative approval
- TAPENTADOL 150MG · Tablet, extended releaseANDA206418-003 · Tentative approval
- TAPENTADOL 50MG · TabletANDA204971-001 · Tentative approval
- TAPENTADOL 150MG · Tablet, extended releaseANDA204972-003 · Tentative approval
- TAPENTADOL 50MG · Tablet, extended releaseANDA204972-001 · Tentative approval
- TAPENTADOL 200MG · Tablet, extended releaseThis page
- TAPENTADOL 100MG · Tablet, extended releaseANDA204972-002 · Tentative approval
- TAPENTADOL 250MG · Tablet, extended release
At a glance
- Brand name
- Tapentadol
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Actavis Elizabeth
- Status
- Tentative approval
- FDA approval
- 24 May 2017
- Application
- ANDA204972-004